Fujifilm and Mitsubishi in Bio-CMO Pact

Fujifilm and Mitsubishi have signed an agreement for biopharma contract manufacturing.

Fujifilm and Mitsubishi have established a partnership in for biopharma contract manufacturing.

The companies have signed an agreement to transfer the ownership of 20% equity interests in Fujifilm's wholly-owned biopharmaceutical contract manufacturing subsidiaries, Fujifilm Diosynth Biotechnologies U.S.A. Inc. (FDBUS) and FUJIFILM Diosynth Biotechnologies UK Limited (FDBUK), to Mitsubishi Corporation.

Mitsubishi Corporation will become involved in the business management of FDBUS and FDBUK alongside Fujifilm in a joint effort to strongly promote the expansion of the bio-CMO business.